Form 4: Medtronic EVP Sells $3.06M in Ordinary Shares

Medtronic's EVP of Global Operations and Supply Chain, Gregory L. Smith, sold 30,000 ordinary shares for approximately $3.06 million.

Summary

• Gregory L. Smith, Executive Vice President of Global Operations & Supply Chain at Medtronic plc (MDT), reported the sale of company ordinary shares.
• The transactions occurred on November 19, 2025, and were made pursuant to a Rule 10b5-1 pre-arranged trading plan.
• A total of 30,000 ordinary shares were disposed of across multiple transactions.
• The shares were sold at prices ranging from $101.93 to $102.08 per share.
• The total approximate value of the shares sold is $3,058,373.26.
• Following these transactions, Gregory L. Smith beneficially owns 46,016 ordinary shares directly.
• The reported beneficial ownership includes 323 shares acquired through dividend reinvestment and 96 shares acquired under Medtronic's Employee Stock Ownership Plan since the last report.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While it's an insider sale, it was conducted under a pre-arranged 10b5-1 plan, which suggests a systematic approach to managing personal finances rather than a reaction to specific negative company news. This typically mitigates the negative perception often associated with insider selling.

Positives

• The transactions were executed under a Rule 10b5-1 plan, indicating a pre-arranged and systematic sale rather than a reaction to immediate company news, which can mitigate negative investor perception.

Negatives

• An executive selling a significant number of shares, even if pre-planned, can sometimes be perceived negatively by investors as it reduces the insider's direct equity stake in the company.

Risks

• While the sale is pre-planned, a large insider sale could potentially lead to minor negative sentiment among some investors, who might interpret it as a lack of confidence, despite the 10b5-1 plan.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding Medtronic's future outlook.

Industry Context

This filing is an insider transaction report specific to an executive's personal stock holdings and does not provide information directly related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: May observe a slight, temporary dip in sentiment due to an executive's share sale, though the 10b5-1 plan context often lessens this impact.

Key Dates

Recommendation

The sale of shares by an executive, while notable, was conducted under a pre-arranged 10b5-1 plan. This indicates a planned diversification or liquidity event rather than a reaction to new, negative information about the company. As such, this single transaction is unlikely to be a significant indicator for a change in investment recommendation for Medtronic plc, which should be based on broader financial performance, strategic outlook, and market conditions. Therefore, a 'hold' recommendation remains appropriate based solely on this filing.

Keywords

Medtronic, MDT, Insider Trading, Stock Sale, Form 4, Executive Compensation, Gregory L. Smith, 10b5-1 Plan